1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Cardiac Prosthetic Devices Market
2.2. Global Cardiac Prosthetic Devices Market, By Device, 2023 (US$ Million)
2.3. Global Cardiac Prosthetic Devices Market, By Geography, 2023 (US$ Million)
2.4. Attractive Investment Proposition by Geography, 2023

3. Cardiac Prosthetic Devices Market: Competitive Analysis
3.1. Market Positioning of Key Cardiac Prosthetic Devices Market Vendors
3.2. Strategies Adopted by Cardiac Prosthetic Devices Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032

4. Cardiac Prosthetic Devices Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Cardiac Prosthetic Devices Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Heart Valve
5.3.1.1. Mechanical Heart Valve
5.3.1.2. Tissue Heart Valve
5.3.1.3. Transcatheter Heart Valves
5.3.2. Pacemakers
5.3.2.1. Implantable Pacemakers
5.3.2.2. External Pacemakers
5.3.3. Artificial Heart


6. North America Cardiac Prosthetic Devices Market, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
6.3.Cardiac Prosthetic Devices Market: By Region, 2022-2032, USD (Million)
6.3.1.North America
6.3.1.1. U.S.
6.3.1.1.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
6.3.1.2. Canada
6.3.1.2.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
6.3.1.3. Rest of North America
6.3.1.3.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)

7. UK and European Union Cardiac Prosthetic Devices Market, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
7.3.Cardiac Prosthetic Devices Market: By Region, 2022-2032, USD (Million)
7.3.1.UK and European Union
7.3.1.1. UK
7.3.1.1.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
7.3.1.2. Germany
7.3.1.2.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
7.3.1.3. Spain
7.3.1.3.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
7.3.1.4. Italy
7.3.1.4.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
7.3.1.5. France
7.3.1.5.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
7.3.1.6. Rest of Europe
7.3.1.6.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)

8. Asia Pacific Cardiac Prosthetic Devices Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
8.3.Cardiac Prosthetic Devices Market: By Region, 2022-2032, USD (Million)
8.3.1.Asia Pacific
8.3.1.1. China
8.3.1.1.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
8.3.1.2. Japan
8.3.1.2.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
8.3.1.3. India
8.3.1.3.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
8.3.1.4. Australia
8.3.1.4.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
8.3.1.5. South Korea
8.3.1.5.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
8.3.1.6. Rest of Asia Pacific
8.3.1.6.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)

9. Latin America Cardiac Prosthetic Devices Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
9.3.Cardiac Prosthetic Devices Market: By Region, 2022-2032, USD (Million)
9.3.1.Latin America
9.3.1.1. Brazil
9.3.1.1.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
9.3.1.2. Mexico
9.3.1.2.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
9.3.1.3. Rest of Latin America
9.3.1.3.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)

10. Middle East and Africa Cardiac Prosthetic Devices Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
10.3.Cardiac Prosthetic Devices Market: By Region, 2022-2032, USD (Million)
10.3.1.Middle East and Africa
10.3.1.1. GCC
10.3.1.1.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
10.3.1.2. Africa
10.3.1.2.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)
10.3.1.3. Rest of Middle East and Africa
10.3.1.3.1. Cardiac Prosthetic Devices Market: By Device, 2022-2032, USD (Million)

11. Company Profile
11.1. Medtronic PLC
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Portfolio
11.1.4. Strategic Initiatives
11.2. Boston Scientific Corporation
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Portfolio
11.2.4. Strategic Initiatives
11.3. Edwards Lifesciences Corporation
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Portfolio
11.3.4. Strategic Initiatives
11.4. Abbott Vascular (Abbott Laboratories, Inc.)
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Portfolio
11.4.4. Strategic Initiatives
11.5. Sorin Group
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Portfolio
11.5.4. Strategic Initiatives
11.6. Biotronik
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Portfolio
11.6.4. Strategic Initiatives
11.7. CryoLife, Inc.
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Portfolio
11.7.4. Strategic Initiatives
11.8. Lepu Medical Technology Co. Ltd.
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Portfolio
11.8.4. Strategic Initiatives
11.9. Meril Life Sciences Pvt. Ltd.
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Portfolio
11.9.4. Strategic Initiatives
11.10. Abiomed, Inc.
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Product Portfolio
11.10.4. Strategic Initiatives
11.11. SynCardia Systems, LLC
11.11.1. Company Overview
11.11.2. Financial Performance
11.11.3. Product Portfolio
11.11.4. Strategic Initiatives
11.12. Carmat
11.12.1. Company Overview
11.12.2. Financial Performance
11.12.3. Product Portfolio
11.12.4. Strategic Initiatives